David-Alexandre C. Gros, MD, CEO at Eledon, discusses the milestone and the role of immunosuppression regimens for durable ...
The first clinical trials using organs from genetically modified pigs offer hope to patients with kidney failure, who face a ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results